(E)-N-(6-((3,5-dimethyladamantan-1-yl)amino)hexyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide

ID: ALA4560240

PubChem CID: 155558583

Max Phase: Preclinical

Molecular Formula: C28H42N2O3

Molecular Weight: 454.66

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(/C=C/C(=O)NCCCCCCNC23CC4CC(C)(CC(C)(C4)C2)C3)ccc1O

Standard InChI:  InChI=1S/C28H42N2O3/c1-26-15-22-16-27(2,18-26)20-28(17-22,19-26)30-13-7-5-4-6-12-29-25(32)11-9-21-8-10-23(31)24(14-21)33-3/h8-11,14,22,30-31H,4-7,12-13,15-20H2,1-3H3,(H,29,32)/b11-9+

Standard InChI Key:  RBRMEBJXSQTZBH-PKNBQFBNSA-N

Molfile:  

 
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   10.3026  -21.7587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9419  -21.0774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1036  -21.5317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6507  -21.3334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8533  -21.8316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3956  -21.1497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1009  -20.6831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6563  -20.0314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9375  -20.2812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4013  -20.3344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0981  -22.3531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6512  -19.2081    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.2162  -21.1174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9368  -18.7999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2275  -19.2171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5131  -18.8088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8080  -19.2260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0936  -18.8178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3844  -19.2350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6700  -18.8268    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9607  -19.2439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2463  -18.8357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9659  -20.0652    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5371  -19.2529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8227  -18.8447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8211  -18.0261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1117  -17.6221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4015  -18.0352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4093  -18.8607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1234  -19.2652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6865  -17.6321    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1069  -16.8008    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8122  -16.3839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  3  5  1  0
  4  6  1  0
  5  6  1  0
  7  8  1  0
  3  7  1  0
  2  9  1  0
  6 10  1  0
 10  8  1  0
  8  9  1  0
  3 11  1  0
  8 12  1  0
  6 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
 22 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 28 31  1  0
 27 32  1  0
 32 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4560240

    ---

Associated Targets(Human)

GRIN1 Tclin Glutamate NMDA receptor; GRIN1/GRIN2A (719 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SH-SY5Y (11521 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
H4 (3266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 454.66Molecular Weight (Monoisotopic): 454.3195AlogP: 5.43#Rotatable Bonds: 11
Polar Surface Area: 70.59Molecular Species: BASEHBA: 4HBD: 3
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.87CX Basic pKa: 11.20CX LogP: 3.75CX LogD: 1.88
Aromatic Rings: 1Heavy Atoms: 33QED Weighted: 0.31Np Likeness Score: 0.14

References

1. Rosini M, Simoni E, Caporaso R, Basagni F, Catanzaro M, Abu IF, Fagiani F, Fusco F, Masuzzo S, Albani D, Lanni C, Mellor IR, Minarini A..  (2019)  Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's disease.,  180  [PMID:31301562] [10.1016/j.ejmech.2019.07.011]
2. Singh YP, Rai H, Singh G, Singh GK, Mishra S, Kumar S, Srikrishna S, Modi G..  (2021)  A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease.,  215  [PMID:33662757] [10.1016/j.ejmech.2021.113278]

Source